"The
Report Bladder Cancer - Pipeline Review, H1 2016 provides information
on pricing, market analysis, shares, forecast, and company profiles
for key industry participants. - MarketResearchReports.biz"
Global
Markets Directs,
Bladder Cancer - Pipeline Review, H1 2016,
provides an overview of the Bladder Cancer pipeline landscape.
The
report provides comprehensive information on the therapeutics under
development for Bladder Cancer, complete with analysis by stage of
development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved
in therapeutic development for Bladder Cancer and features dormant
and discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Download Sample copy of this
Report at:
Scope
-
The report provides a snapshot of the global therapeutic landscape of
Bladder Cancer
-
The report reviews pipeline therapeutics for Bladder Cancer by
companies and universities/research institutes based on information
derived from company and
industry-specific
sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report reviews key players involved Bladder Cancer therapeutics
and enlists all their major and minor projects
-
The report assesses Bladder Cancer therapeutics based on drug target,
mechanism of action (MoA), route of administration (RoA) and molecule
type
-
The report summarizes all the dormant and discontinued pipeline
projects
-
The report reviews latest news related to pipeline therapeutics for
Bladder Cancer
Reasons to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand important and diverse types of therapeutics
under development for Bladder Cancer
-
Identify potential new clients or partners in the target demographic
-
Develop strategic initiatives by understanding the focus areas of
leading companies
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Bladder Cancer pipeline depth and focus of Indication therapeutics
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
-
Modify the therapeutic portfolio by identifying discontinued projects
and understanding the factors that drove them from pipeline
Follow us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Table of Contents
Table of Contents 2
Introduction 7
Bladder Cancer Overview 8
Therapeutics Development 9
Bladder Cancer - Therapeutics
under Development by Companies 11
Bladder Cancer - Therapeutics
under Investigation by Universities/Institutes 20
Bladder Cancer - Pipeline
Products Glance 21
Bladder Cancer - Products under
Development by Companies 24
Bladder Cancer - Products under
Investigation by Universities/Institutes 33
Bladder Cancer - Companies
Involved in Therapeutics Development 34
Bladder Cancer - Therapeutics
Assessment 128
Drug Profiles 148
Bladder Cancer - Recent
Pipeline Updates 433
Bladder Cancer - Dormant
Projects 647
Bladder Cancer - Discontinued
Products 655
Bladder Cancer - Product
Development Milestones 656
Appendix 661
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment